SenseGuard™ is a reliable solution for monitoring patients with respiratory diseases, such as COPD. It is a wireless, wearable device that enables continuous and non-invasive monitoring of lung function of patients in both healthcare and home settings. SenseGuard™ is leveraging on a unique  technology - nano-based respiration sensors. Thanks to them, it seamlessly monitors patient’s normal (tidal) breathing, whether at rest or during activity. From it, the device extracts critical respiratory parameters (e.g. respiration rate, inhalation/exhalation times and ratio, apneas and more) for caregivers to check on patients' condition, manage their illness and early alert on pending exacerbations to allow treatment while the patient is still at home.

Competitive advantage: SenseGuard™  is a passive and continuous measurement of tidal breathing leveraging on a unique nanosensor technology, without any complicated actions required by the patient and/or operator. The device requires no patient cooperation or forced inhalation/exhalation test execution, unlike current technologies such as spirometry. SenseGuard™ monitoring test is not unpleasant or painful, which spikes up patient adherence to perform it. Its measurements are accurate in contrast to spirometry where the patient can do the breathing in a wrong manner and get a misleading result. SenseGuard™  can be used remotely or at the hospital to collect the patient’s pulmonary parameters. The patients' data is transmitted to a monitoring station, where the caregiver processes the information and responds with feedback about the management of the illness. SenseGuard™ allows to set thresholds in order to identify deviations from baseline values that can be indicative of an upcoming COPD exacerbation before it reaches critical stage. This contributes to reduced hospital admissions of patients and associated costs, while improving their health outcomes and quality of life.

Aptar has developed an add on sensor that is designed to sit on the top of a pressurised metered does inhaler.
Adherence and compliance in Asthma patients is notoriously low. It can be as low as 40%. The job of the sensor is to give patients contextual reminders to ensure they take their medication and they take it correctly. Should they not take their medication correctly they will suffer symptoms, an exacerbation leading to hopsitalisation and potentially death.
In addition to the reminders, it can also give feedback to the patient on their inspiratory flow rate this enabling the patient to have more understanding on how the medication is improving inhalation.
The data can be collated and shared with the physician at their regular checks.
So the system will improve the lives of patients and also help to drive down the cost on the healthcare system.

EverInspire Ltd is an online platform that uses the latest scientific research to design innovative programs that can positively impact mental health and wellbeing.  When adopted by organisations as part of their staff wellbeing provision, EverInspire’s programs can positively impact important metrics such as engagement.  Our RCT has also shown that our programs can significantly impact depression, anxiety and stress.

The EverInspire business model operates through three strands.

1. EverInspire Workplace is a subscription service provided through a LMS.  Once subscribed organisations gain access to evidence – based programs designed to improve individual and whole organisational wellbeing.  The digital aspect allows the programs to be disseminated widely at low cost.  These programs can also be licensed and hosted on the organisation’s LMS.  Research has shown that people would prefer to access wellbeing programs digitally and research into effective digital interventions is still in its infancy - this is where we aim to innovate.

2. EverInspire Public is a ‘free upon entry’ platform that facilitates interactions between wellbeing professionals (e.g. researchers, therapists or coaches) and the public. It does this by offering offering a directory of wellbeing professionals plus access to our online programs designed for the general use.  Our professionals are specialist Positive Pscyhology Coaches who have obtained or currently studying for a Master's in Positive Psychology Coaching. We check credentials such as qualifications, insurance and ICO registration.  Our professionals receive training on the protection of vulnerable adults and know when to signpost to specialist support.  The products on EverInspire are only available to working age adults. 

3. EverInspire is also a social enterprise and allocates 51% of our profits for our social cause. 
   
Our professionals can contribute material to the platform, however all material is curated by EverInspire. This includes a thorough check of the evidence base.

We introduce our clients to the research based Uni-being model, which is designed to help organisations and individuals understand the whole spectrum of mental health and wellbeing.  The model helps to identify individual or organisational strengths and weaknesses for wellbeing and aids discussions about where one could choose to focus their attention. 

EverInspire has a strong focus on research, evidence, client choice, collaboration, creativity and safety.



 

I am a student nurse who is currently developing an assignment on an innovation. My idea was to introduce a pressure releif system on the vital packs similar to the presentation for observations. I have observed in practice how it is difficult to keep on top of the different times different service users need pressure releif. I beleive this system would be an advantage not only for service husers health but for the staff on the ward as they will know when pressure releif is due for a service user by teh same alarm as the obersrvation. I beleive this improve service users health by also preventing the risk of DVTs and onitoring any skin deteriorationwhilst keeping a simple system throughut the day which is easy to follow. I also beleive this would be a simple addition to the vital packs which is cost effective. If anyone is able to read this and give me any tips or ideas how I could go about inventing this, or finding someone to contact I would be very greatful!

GrandCARE is a touchscreen device filled with a number of features.

Figures issued by the Adult Social Care Activity and Finance Report showed that 857,770 people received long term care support from Councils in 2017-18.  Local Authorities pay an average of £15.52 to external care providers for one hour of home care.
 
grandCare has just finished reviewing the results of a twelve-month pilot for a local Council. Each user was supplied with a grandCare unit and a mixture of sensors with the aim to

• Improve safety
• Empower independence, choice and inclusion
• Making independent living more sustainable
• Providing services in an increasing cost-effective way

Rehab Me offers GP’s a tool to help advise and support their patients without necessarily referring them to a physio for a scan or prescribing pain medication. It provides easy to access evidenced based advice sheets, treatment plans and interactive prompts to support compliance and outcome tracking, as well as signposting patients to further support and prevention pathways.
 
How it works: A simple digital solution, accesses on-line or via a downloadable all which operates on a stand-alone basis or be integrated into existing GP systems.
 
Step 1 - patient injury or MSK condition identified by GP who then prints off the relevant advice sheet from the Rehab Me website. This provides evidence-based exercises and advice regulated by standard physiotherapy practice and directs patient to the Rehab Me website for the patient to register.

Step 2 - patient registers on the Rehab Me website and selects the treatment plan advised by the GP. This will then provide scheduled exercises including frequency and number of repetitions across the treatment plan period. This is automatically linked to the patient’s calendar to enable reminders and prompts over the treatment period which can be anywhere between 6-10 weeks.
 
Step 3 - the patient can access the plan via the website or a downloadable app. The patient will be prompted each day and guided by their virtual physio with the use of easy to follow HD videos and/ or detailed descriptions.  Patients track their own adherence and progress through the website or via the app. They can also record and track pain each day to help assess progress and provide PROM data for their GP.
 
Step 4 – at any time the GP can view progress and results for a patient on a treatment plan; and if appropriate advice on a new exercise plan virtually so the patient can progress without the need for another appointment.
 
Step 5 – during or after a course of treatment, Rehab Me can signpost access to other relevant resources to encourage people to adopt exercise into their everyday lives to prevent relapse. This includes a social prescribing section encouraging patients to join gyms, walking clubs etc.
 
Part of the service provided by Rehab Me includes educational training on MSK issues as part of the process to this new pathway for GP’s to adopt in their practice.

The Rehab Me data platform adheres to appropriate NHS data IG and GDPR requirements, with all data securely stored on a cloud based server.
 

The Amplitude pro enterprise™ software is a simple, tailored online platform centred around two crucial elements:
A user-friendly electronic patient portal which gives patients the freedom of completing their scores online at home, on site and via various devices and a consultant dashboard giving the clinician(s) the ability to input patient specific complexity factors and procedure data quickly and easily.

The result is representative, accurate and meaningful data that paints a clearer picture of each patient’s level of health and expected recovery. Clinicians are engaged with the clinical outcomes processes at your hospital, you get the insight required to innovate your clinical services and patients get a consistently high standard of care.

pro enterprise™ is simple, cost effective and delivers precise and accurate data, selecting scores that are identified as important to you.

The data you collect in pro enterprise™ will allow you to monitor your service delivery, identify quality issues and demonstrate levels of care. Your hospital can be confidently transparent about its activities, resulting in reassurance to your peers that you are offering the best care possible.

Amplitude specialises in the collection of electronic PROMs and clinical outcomes and we are the leading supplier of electronic PROMs to the NHS. We are accredited by NHS Digital for the electronic capture and upload of National PROMs and our platforms have achieved the highest levels of IG compliance, using data centres that are ISO27001 certified. 

Amplitude's unique data exchange tool means that you enter and retain your data locally in your pro enterprise™ platform and the necessary data for clinical registries, National PROMs and NJR can be  pushed to the relevant databases on your behalf.

Our systems are designed to empower clinicians in adding value to their data e.g. proper case mix adjustment, log-book, revalidation report and easy analysis and self-monitoring tools. The system automates the process of data collection via a series of reminders sent to patients via email and SMS. These reminders are triggered from the intervention data which at minimum includes procedure/intervention description and diagnosis. 

Amplitude pro enterprise™ is customised and tailored to suit specific department requirements and objectives including virtual clinics, clinical outcomes and PROMs. pro enterprise™ is currently being used in T&O, Rheumatology, Urology, Cardiology and Mental Health departments.

ChatHealth is a safe and secure text messaging service that helps families and young people get in touch with healthcare professionals. First developed by school nurses at Leicestershire Partnership NHS Trust (LPT), ChatHealth supports greater efficiencies within public health community nursing teams, with individual nurses able to provide for a greater number of service users. It is cost effective and uses technology millennials are familiar with, providing confidential and timely access to healthcare. People who need health advice and support do not need to wait for a nurse visit and the service is completely anonymous meaning it reaches out to often seldom-heard and vulnerable groups.

• Available to nearly two million young people in England.
• Available to the parents/carers of nearly 80,000 new-born babies a year.
• Increased service reach/access - delivering 100 additional contacts every month.
• Overcomes the stigma of face-to-face discussion of sensitive issues.
• Reaches more underserved groups - 1 in 5 male users compared to 1 in 10 in face-to-face clinics.

Xuper Clinic is a perfect combination of an appointment booking system and a video consultation platform, which has been designed to streamline patient and doctor interaction. It is designed to enhance the communication and collaboration for all parties involved by saving them time and money.
Our solution allows organisations to customise their workflows and narrate what the end product will look like and how it will work for them. It also provides an end-to-end solution within healthcare, where trusts can use the platform to not only book their patient appointments, but also use the same platform to conduct encrypted and highly secure video consultations. It allows the patients to log into their consultation(s) with a onetime use pin, ensuring that the platform remains secure from unwarranted access. Our platform allows the healthcare organisation to define the data they hold, enabling it to remain consistent with the rest of their systems and any protocols in place. As for Xuper, all of the patients data remains anonymous, we simply maintain information on the platforms usage, such as hours in use and healthcare areas it is being used in. It also has the capability to integrate with existing Patient Appointment Systems (PAS) to ensure a seamless process.
Xuper Clinic is also designed to integrate with external diagnostic tools such as digital stethoscopes for further collection of data, continuity of care and feasibility. Most importantly, the platform integrates with market leaders in wearable technology, Fitbit, which allows consultants to track their patients’ sleep, physical activity and calories burnt for health monitoring purposes.
Current software’s which exist in the market for telemedicine, solely provide a platform for video consultation or telemedicine, however, lack a more thorough or end-to-end solution for continuity of care.

As it could be integrated and is constantly receiving data from current lab and EHR systems, it immediately detects problems in lab test results and informs doctors about new lab data received and issues detected for a particular patient. It gives access to historical data with some valuable statistical calculated and visualised data which helps doctors to understand acute, chronic, hidden or early stage health problems over secure web/mobile/tablet applications, so doctors can see these results for making better and correct decisions any time and in any location they are in at any moment.
 
Core applications of the solution are:
1. Speeding up doctors’ workflow in hospitals. At the moment, doctors in NHS have to go to rooms where there are computers with access to lab data. Quite often, doctors spend time waiting for each other to get access to their patient blood test data.

An essential part of the solution is the mobile/tablet application which can be installed on any mobile operation system iOS/Android. Which lead to:

• Freeing up to 2 hours of doctors’ time daily
• Increasing patient turnaround time on average by 25%
• Increasing time reaction on most critical acute cases up to 99% 

2. In Doctors’ practice, there have been cases when a delay in days, hours or minutes in getting lab data in time is crucial for a patient’s life.  

Platform is constantly tracking blood data from the lab system, it analyzes it and alerts about critical changes in lab tests metrics and it immediately sends notifications to related parties to pay attention on a particular case.
​
At the moment, it tracks more than 25+ diseases and all other blood test parameters and (early and acute): AKI + CKD (all types), Sepsis and much more.

3. Platform provides historical analysis tools for blood results and gives some related insight information for each particular test parameter, so it is quick and easy to see the problem and identify potential problems at a very early stage and apply preventive actions to avoid problems. 

4. Platform has a recommendation system which seeks potential hidden problems in results. If those potential hidden problems are found, the platform gives an explanation and list of additional tests required to confirm potential problems.

5. For management team it provides deep business insight (visulised with over the time progression) of a difference scale: Hospital, Groups of Hospitals and National level about detected problems, about performance of laboratories, doctors and etc.

Kemuri K-Sockets are power sockets with multiple sensors that continuously measure:

• Movement of people in the kitchen;
• Electrical power for kettles, microwaves or toasters;
• Room temperature;
• Power supply.

They send data via the Internet via GSM mobile phone communications.  Kemuri software learns patterns of normal activity and analyses Activities of Daily Living (ADLs) every hour.  As soon as the system identifies too many changes from normal, it automatically alerts people who need to respond to possible risks.  Responders can be families, carers or 24/7 alarm response centres.

The WebApp gives evidence of reablement of the service users.  It gives confidence to responders who have been given informed consent to view the data.  For example:

• Wandering or unattended falls: Kemuri alerts non-return to kitchen;
• Nutrition & Hydration: Kemuri alerts risk of dehydration or malnutrition;
• Engaged the Community: Kemuri apps are free to authorised family, carers or voluntary sector;
• Active in the home: If people can eat, drink and move around in warm surroundings – then they are performing key ADLs.

Portable K-Sockets are allocated to discharge teams as part of the normal hospital discharge process. Families or other carers have to respond to alerts and determine the action to be taken.  The devices are re-allocated to patients every 6 weeks. Thereafter fixed K-Sockets can be installed in kitchens as wellbeing monitors. 



The cost is less than £500 per year, and the notional saving on bed days is approximately £400 per day.  By using a unit eight times per year, more than £3200 budget is released for more patients.  This represents more than 500% return on investment in one year.  This must be worth a trial in the region.  Additional benefit can come from reduced re-admissions.

Surrey County Council have awarded a grant of £50,000 for measuring the reablement process and subsequent wellbeing monitoring.

Cera is a digital disruptor of the home care space, with in-house and proprietary technology. We have created a platform able to i) create digital care reports whereby during a carer visit, carers log information on their smartphone using our platform, with health and behaviour data on the user, which allows for metrics to be monitored and better care to be delivered – this data is also accessible to family members and healthcare professionals permitting much better connected services; ii) use of artificial intelligence based on the data collected by carers, to predict if users are going to experience health deteriorations such as their blood pressure worsening or the onset of a urine infection, based on subtle signals that carers may have logged – this allows us to escalate a service user’s care should they be at high risk of deterioration, or contact their doctor more proactively, potentially preventing adverse health events or the need to go to hospital; iii) use of an artificial intelligence chatbot – Martha – that provides decision support to carers based on questions they ask. The chatbot aims to transfer some of the knowledge and experience which established carers possess to carers with less experience; by doing this, we aim to make care more consistent.

Cera has provided hundreds of thousands of care hours with a 95% satisfaction rating, and is growing at an average of 25% a month. It has received over £13 million of funding from investors such as Kairos Ventures, Kima Ventures, David Buttress (former CEO of JustEat), Paul Wilmott (leads digital globally for McKinsey), Charles Songhurst (former Global Head of M&A at Microsoft) and Peter Sands (former Chairman of Davos). It has been recognised by the Government's Cabinet Office as a role model for innovative businesses partnering with the public sector, and Sir Nick Clegg recently joined the company. Cera has received a number of awards including the Most Outstanding Digital Health Innovation of the Year, the LaingBuisson Dementia Care Award, the Best London Home Care Company at the Social Care Awards 2018.

CliniTouch Vie is a digital health solution that reduces unnecessary hospital admissions.
 
CliniTouch Vie is a locked-down tablet with integrated 3G for intensive monitoring, education & empowerment with integrated direct messaging & video support.  Dynamic care plans & evidence-based algorithms enable automatic triage for healthcare teams.  Fast & simple to implement for the most at-risk patients. 
 
Launched in 2016, system is CE marked & MHRA approved. An evidence based digital health platform that clinically supports patients to better manage their condition. It has the flexibility to be adapted for data analytics & clinical decision-making support in chronic disease management (eg COPD, heart failure & diabetes), frailty & assisted discharge programmes for ambulant & non-ambulant patients
 
Clinical & economic evidence has been generated from trials with 300 respiratory patients [Ghosh et al, 2016, https://doi.org/10.12968/bjhc.2016.22.3.123]. Our evidence based digital solution increases patient access to care & promotes greater clinician-patient collaboration for the 15million people with LTCs. It drives timely, proactive intervention, minimising need for more acute costly care enabling sustainable long-term outcomes success
 
USPs:
Evidence based: Study published in the British Journal of HC Management showed 67% reduction in unscheduled COPD admissions & saving of £2,278 per patient pa. (NB: programme continues to deliver same level of savings)
 
Patient-centred: Personalisation of goals, metrics & parameters makes system truly patient centred providing real-time remote monitoring closer to home to improve patient experience & outcomes whilst generating savings
 
Secure & integrated: Data server sits within HSNC enabling it to push-pull data securely between healthcare provider & service users. Includes bespoke integrated secure video-conferencing platform with end-to-end encryption, allowing remote monitoring of medical conditions, improving quality of life & avoiding unnecessary admissions
 
Flexible Modular Architecture: Enables clinically validated question sets re: symptoms, to be easily tailored to specific therapy areas for qualitative data collection
 
Tiered Service: no upfront costs to NHS on PAYG basis:
- Digital platform integrated into existing healthcare pathways
- Light touch triage service informing local health teams of urgent priority patients for interventions
- Fully-Managed digital platform and nurse-led service providing triage & interventions

Healthcare professionals need to stay up to date on the latest medical research and topic reviews to provide optimal care. Unfortunately, the process of content discovery is broken with research artificially compartmentalised by publishers and hidden behind countless institutional paywalls.

At QxMD, we believe that knowledge translation– the process by which new knowledge is incorporated into clinical practice – is an important and unsolved challenge for our health care system. Read uses smart algorithms to ensure that each and every user has a dedicated newsfeed of research that applies to their practice. 
With Read, Institutional Edition, organisations can seamlessly integrate their existing journal subscriptions and existing proxy service to provide a platform for their clinical staff to access content which matters to their individual practices. It is built with features designed to improve patient care and reduce costs. 

The Promoted Research feature is used by institutions who want to disseminate research that impacts areas of care the most within their organisation. For example, a Hospital with high rates of Sepsis can use this tool to promote guidelines that reduce Sepsis cases with higher guarantees their clinical staff will discover the research and apply it to the next patient. 

Librarians and Knowledge Managers can take advantage of smart analytics to understand which journal subscriptions are performing the best and worst and also which journals are most popular, which they don't subscribe to.

NHS Trusts are already adopting QxMD, with over 100,000 users in the UK alone. 

Currently
The vast majority of patients with Obstructive Sleep Apnoea (OSA) are referred by their GP to a Specialised Sleep Centre at an NHS Hospital with a Average waiting time 12 Weeks


Patients are initially seen by a Consultant or a Sleep Physiologist who would prescribe a Diagnostic Study to be performed either in hospital or at the patient’s home. Average waiting time 12 Weeks
The patient returns to have the sleep study done or to collect the monitor and then returns the device the next day. After a further waiting time of upto 6 Weeks the patient visits the hospital again to obtain the results of the sleep study and if Positive, to discuss treatment.
A letter is sent to the GP informing them of the results and if agreed, a prescription is issued by the GP for the recommended therapy this may also take an average of 6 Weeks to arrive.
 This is prior to any treatment being administered such as a CPAP where if used they attend annually to check on compliance and progress.
 
This 6 month process is dramatically reduced by the S-Med Service to just a few days before an intervention can be delivered.


Now
The GP fits SOMNOtouch, a Combined OSA/Hypertension Monitoring Device to the patient, after 24 hours they return to the GP practice where the device is removed and the GP uploads the data from the device to a secure NHS Digital Cloud Server.

Video link: http://www.s-med.co.uk/Products#nav-product-86
 
S-Med Ltd’s Qualified and Registered Physiologists interprets the study and provides a recommendation for further treatment or investigation within 24 to 48 hours to the GP surgery. (All analysis and interpretations are supervised by a senior Consultant).
 
The report is sent to the GP who would then provide a prescription for the relevant therapy to be provided.
 
Thus within 48 to 72 hours a patient can be treated or directed for additional investigations or treatment before their condition deteriorates.